The supplemental indication for satralizumab, already sold for a rare neuroinflammatory disease, is another example of the recent marked growth in approved treatments for thyroid eye disease. Medscape Medical News
Category: News
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
GENEVA–(BUSINESS WIRE)–FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
FDA Approves New Nonprescription Treatment for Eye Redness
Brytly is the first over-the-counter eye drop containing apraclonidine and is approved for adults and children ages 12 and older. Medscape Medical News
AAO 2026: Accurate Diagnosis and Emerging Wet AMD Therapies
Reflections from AAO 2026 on how accurate diagnosis, individualized treatment, and emerging therapies could improve wet AMD care and reduce treatment burden. Medscape
Recognizing Cortical Visual Impairment in Children
Cortical visual impairment is the leading cause of blindness in children in the developed world and is increasing in incidence. Medscape Medical News
FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $RHHBY–Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Enspryng® (satralizumab-mwge) for the treatment …
Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2026, will be released befor…
Varicose Veins Tied to Risk for Fluid Buildup Under Retina
Adults with varicose veins show about twice the risk for a later diagnosis of central serous chorioretinopathy, a retinal fluid disorder, a large retrospective study suggests. Medscape Medical News
Varicose Veins Tied to Risk for Fluid Buildup Under Retina
Adults with varicose veins show about twice the risk for a later diagnosis of central serous chorioretinopathy, a retinal fluid disorder, a large retrospective study suggests. Medscape Medical News
Congenital CMV: Which Infants Need an Eye Exam?
Few asymptomatic, CMV-positive newborns have signs on screening of eye abnormalities. Medscape Medical News
Study Shows Potential of Omitting Speculum in Eye Injections
A meta-analysis finds less pain with manual eyelid retraction than with a speculum and fewer complications with device-assisted techniques. Medscape Medical News
AAO 2026
Read clinically focused news coverage of key developments from AAO 2026. Medscape Ophthalmology
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that Bausch + Lomb Board of Directors Chairman Tho…
Can Anti-VEGF Cause More Complications in DME Patients?
A study of more than 40,000 diabetic patients found the injectable treatment associated with a nearly threefold increased risk for ocular hypertension or glaucoma over 5 years. Medscape Medical News
Switch to Faricimab May Extend Dosing Intervals in nAMD
Switching from aflibercept to faricimab is linked to longer dosing intervals and better fluid control over 3 years among patients with treatment-resistant neovascular age-related macular degeneration. Medscape Medical News
Switch to Faricimab May Extend Dosing Intervals in nAMD
Switching from aflibercept to faricimab is linked to longer dosing intervals and better fluid control over 3 years among patients with treatment-resistant neovascular age-related macular degeneration. Medscape Medical News
Carrot Announces Agreement to Acquire GreenMan InSightVR, Expanding Eye Care’s Leading VR Diagnostics Platform Into Vision Simulation
BROOKLYN, New York–(BUSINESS WIRE)–Carrot (formerly Virtual Field), the most widely used VR testing and diagnostic platform in eye care, today announced an agreement to acquire GreenMan Vision, Inc., the company behind InSightVR. The deal will add in…
Stuart Therapeutics Expands Pipeline with Corneal Wound Healing Program
STUART, Fla.–(BUSINESS WIRE)–Stuart Therapeutics Inc., a late-stage biopharmaceutical company developing a new class of therapeutics designed to treat eye diseases by repairing helical collagen, today announced it has submitted an investigational new…
Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members b…
STAAR Surgical Names Andrew Pilon as Vice President of Business Development
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointme…